With strategic portfolio expansion, including acquisition of branded urology products and focus on men’s health, we have further strengthened our ability to address unmet needs across the patient journey.
We have established a strong and evolving presence in urology, driven by a commitment to improving patient outcomes through innovation, education, and access to advanced therapies. Our approach integrates robust product development and continuous engagement with the medical community.
With strategic portfolio expansion, including acquisition of branded urology products and focus on men’s health, we have further strengthened our ability to address unmet needs across the patient journey.
We have partnered with the European Association of Urology to enable Indian urologists to access cutting edge research.
We focus on health education and awareness through our ongoing initiatives on World Continence Week and Men’s Health Week.
We have actively contributed to the advancement of the urology segment in India through academic collaborations.
Urology encompasses a wide spectrum of conditions that require both acute and long-term management strategies.
An age-related condition in men that causes enlargement of the prostate gland, leading to urinary symptoms such as frequent urination, weak urine flow, nocturia, and incomplete bladder emptying. BPH can result in complications like urinary retention, bladder stones, or kidney damage.
A condition characterized by involuntary bladder contractions, leading to urinary urgency, increased frequency, nocturia, and sometimes urge incontinence. OAB can be influenced by factors such as nerve-related bladder control issues and dietary triggers, among others. It can significantly impact daily activities and emotional well-being.
These are common bacterial infections in the urinary tract that can affect both men and women across age groups.
Formation of stones in the kidneys and the ureters obstructs the flow of urine and causes pain. It can increase due to dietary and metabolic factors.
Disclaimer: The content on this website/webpage relates to a specific therapy/therapeutic area and is intended solely for informational and educational purposes for healthcare professionals and patients across India and other global locations, is not intended to substitute professional medical advice, diagnosis, or treatment. Advice from a physician or other qualified healthcare professional must be sought for any queries regarding a medical condition or treatment. Information on this website/webpage should not be solely used or relied upon in the absence of or delay in receiving professional medical advice. While Lupin makes reasonable efforts to ensure that the information is accurate and up to date, it makes no representations or warranties regarding its completeness or accuracy and accepts no liability for reliance on such information. The information on this website/webpage is not a substitute for prescribing information or patient information leaflets accompanying any medicinal product. The information on this website/webpage is subject to change without notice and may not reflect the most current medical, scientific, or regulatory developments. All content on this website/webpage is the intellectual property of Lupin and shall not be reproduced, modified, distributed, or used for any commercial purpose without the prior written consent of Lupin.
We offer comprehensive urology portfolio addressing both chronic and acute conditions, enabling improved quality of life for patients.
It is used to treat benign prostatic hyperplasia. It also helps relieve symptoms like difficulty in passing urine.
It is a combination with 5 alpha reductase inhibitors. The therapy is used in managing prostate enlargement.
This is indicated for management of OAB (overactive bladder). It helps relieve urinary urgency and urinary frequency.
Our mirabegron and combination of mirabegron and solifenacin are used for overactive bladder management.
This diversified portfolio helps us in addressing multiple stages of urologic disease progression, from early symptoms to complex chronic conditions.
Our journey in the urology segment is marked by strategic initiatives, partnerships, and measurable impact in advancing care delivery across patient cohorts.
As the burden of urologic diseases continue to rise globally, we at Lupin remain committed to advancing care through innovation, education, and strategic expansion.
With a strong focus on patient-centric solutions, global collaborations, and a growing specialty portfolio, we aim to redefine urology care and improve quality of life for patients worldwide.
